Technical Analysis for EARS - Auris Medical Holding AG

Grade Last Price % Change Price Change
grade F 0.3587 -2.23% -0.01
EARS closed down 2.23 percent on Friday, March 22, 2019, on 15 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
27 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical EARS trend table...

Date Alert Name Type % Chg
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 22 Narrow Range Bar Range Contraction 0.00%
Mar 22 NR7 Range Contraction 0.00%
Mar 22 Inside Day Range Contraction 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 21 Fell Below 20 DMA Bearish -2.23%
Mar 21 Bollinger Band Squeeze Range Contraction -2.23%
Mar 21 BB Squeeze + Lower Band Touch Range Contraction -2.23%
Mar 21 Lower Bollinger Band Touch Weakness -2.23%
Mar 20 20 DMA Support Bullish -5.61%

Older signals for EARS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical trials for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss, as well as for Meniere diseases; and other development programs comprising AM-102 and AM-123 that are in preclinical studies. It has a collaboration and license agreement with Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, and drug delivery devices and formulations for the treatment of inner ear disorders. The company was formerly known as Auris Medical AG and changed its name to Auris Medical Holding AG in April 2014. Auris Medical Holding AG was founded in 1998 and is headquartered in Zug, Switzerland.
Biopharmaceutical Pharmaceutical Products Drug Delivery Nervous System Perception Hearing Loss Auris Drug Delivery Devices Ear Hearing Tinnitus
Is EARS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 15 Auris Medical Announces 20-F Filing
Mar 14 These Four Healthcare Stocks Could Test March Highs
Mar 14 Auris Medical Holding AG (EARS) CEO Thomas Meyer on Q4 2018 Results - Earnings Call Transcript
Mar 14 Auris Medical Holding AG 2018 Q4 - Results - Earnings Call Slides
Mar 14 Auris: 4Q Earnings Snapshot
Mar 14 Auris Medical up 3% on Q4 results
Mar 14 Auris Medical reports Q4 results
Mar 14 Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results
Mar 11 Auris Medical Announces Publication of AM-111 Phase 3 Results in Peer-Reviewed Scientific Journal
Mar 7 Auris Medical to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on Thursday, March 14, 2019
See more EARS news...
Indicators
Indicator Value
52 Week High 2.45
52 Week Low 0.23
Average Volume 1,778,472
200-Day Moving Average 0.5071
50-Day Moving Average 0.3994
20-Day Moving Average 0.3772
10-Day Moving Average 0.3825
Average True Range 0.037
ADX 18.02
+DI 23.2374
-DI 22.8704
Chandelier Exit (Long, 3 ATRs ) 0.349
Chandelier Exit (Short, 3 ATRs ) 0.421
Upper Bollinger Band 0.4093
Lower Bollinger Band 0.3451
Percent B (%b) 0.21
BandWidth 17.020149
MACD Line -0.0068
MACD Signal Line -0.0073
MACD Histogram 0.0005
Fundamentals Value
Market Cap 15.9 Million
Num Shares 44.3 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -0.48
Price-to-Sales 0.00
Price-to-Book 6.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.38
Resistance 3 (R3) 0.38 0.37 0.37
Resistance 2 (R2) 0.37 0.37 0.37 0.37
Resistance 1 (R1) 0.36 0.36 0.36 0.36 0.37
Pivot Point 0.36 0.36 0.36 0.36 0.36
Support 1 (S1) 0.35 0.35 0.35 0.35 0.35
Support 2 (S2) 0.35 0.35 0.35 0.34
Support 3 (S3) 0.34 0.35 0.34
Support 4 (S4) 0.34